New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 25, 2014
09:11 EDTBKW, ADXS, QIHU, X, TRP, INSY, RGDO, RHHBY, ITMN, THI, MRKOn The Fly: Pre-market Movers
HIGHER: Burger King (BKW), up 13% after confirming talks regarding a potential strategic transaction with Tim Hortons (THI). Shares of the Canadian donut shop operator trading in New York are also up 17%... InterMune (ITMN), up 36% after Roche (RHHBY) agreed to acquire the company for $74.00 per share... Advaxis (ADXS), up 4% after entering clinical trial collaboration agreement with Merck (MRK)... Insys Therapeutics (INSY), up 5.5% after receiving FDA orphan drug designation for CBD... TransCanada (TRP), up 2.2% after Barron's says the company could climb 35%... U.S. Steel (X), up 3.7% after upgraded at Credit Suisse. LOWER: Regado (RGDO), down 52% after the company terminated enrollment in its REGULATE-PCI Phase 3 trial... Qihoo 360 (QIHU), down 5% after reporting Q2 earnings, Q3 outlook.
News For BKW;THI;ITMN;RHHBY;RGDO;INSY;TRP;X;QIHU;ADXS;MRK From The Last 14 Days
Check below for free stories on BKW;THI;ITMN;RHHBY;RGDO;INSY;TRP;X;QIHU;ADXS;MRK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 15, 2014
13:45 EDTTHI, BKWTim Hortons up fractionally following preliminary Q3 quarter-to-date SSS report
Tim Hortons (THI) is up fractionally in afternoon trading following the company's pre-market announcement of Q3 quarter-to-date SSS growth results. The company reported Canadian SSS up 3.6% and U.S. SSS up 7.0% for the 9-weeks ended August 31. Tim Hortons released this information in connection with the company's proposed strategic transaction involving 3G Capital and Burger King Worldwide (BKW).
13:30 EDTMRKMerck announces data from pivotal Phase 3 study for odanacatib
Merck announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis. Odanacatib is Merck’s investigational once-weekly cathepsin K inhibitor. In the Long-Term Odanacatib Fracture Trial, odanacatib met its primary endpoints and significantly reduced the risk of osteoporotic hip, spine and non-vertebral fractures compared with placebo. The rates of adverse events overall in LOFT were generally balanced between patients taking odanacatib and placebo. Adjudicated events of morphea-like skin lesions and atypical femoral fractures occurred more often in the odanacatib group than in the placebo group. Adjudicated major adverse cardiovascular events were generally balanced overall between the treatment groups. There were numerically more adjudicated stroke events with odanacatib than with placebo.
12:58 EDTINSYInsys retreats after receiving second subpoena from U.S.
Subscribe for More Information
09:59 EDTTRPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:23 EDTINSYInsys subpoena should not overshadow bigger picture, says Wells Fargo
Subscribe for More Information
07:41 EDTINSYInsys new subpoena an extension of previous probe, says Oppenheimer
After Insys received a subpoena from the Department of Justice after previously receiving a subpoena from an Inspector General's office, the firm thinks the second subpoena is related to the same investigation as the first one. Oppenheimer views the second subpoena as a headline risk but does not expect it to impact the company's business. It keeps a $40 price target and Outperform rating on the shares.
05:31 EDTTRPTransCanada downgraded to Sell from Neutral at Goldman
Subscribe for More Information
September 12, 2014
18:03 EDTINSYInsys Therapeutics receives subpoena over Subsys sales, marketing practices
On September 8, Insys Therapeutics, Inc. received a subpoena issued pursuant to the Health Insurance Portability and Accountability Act of 1996, as amended, from the U.S. Attorney’s Office for the District of Massachusetts. The subpoena requests documents regarding Subsys, including Insys’ sales and marketing practices related to this product. Insys intends to cooperate with the investigation.
14:44 EDTXU.S. Steel receives final approval for Minntac expansion
Subscribe for More Information
09:33 EDTQIHUQihoo 360 management to meet with JPMorgan
Meeting to be held in Boston on September 17 hosted by JPMorgan.
09:21 EDTBKWBlackstone to sell 260 Burger King locations, Bloomberg says
Subscribe for More Information
September 11, 2014
08:09 EDTTHI, BKWBerkshire's Munger defends Burger King deal, WSJ reports
Subscribe for More Information
08:03 EDTTHI, BKWSenators urge Burger King to stay domiciled in U.S., Reuters reports
The number 2 ranking Senate Democrat, Dick Durbin, and four fellow senators have urged Burger King (BKW) to keep its domicile in the U.S. and give up plans for a "tax inversion" as part of its purchase of Canada's Tim Hortons (THI), reported Reuters. Reference Link
September 10, 2014
16:00 EDTMRKOptions Update; September 10, 2014
Subscribe for More Information
13:04 EDTRHHBYRoche unit receives orphan status for lung cancer mutation drug
Subscribe for More Information
10:25 EDTINSYInsys Therapeutics management to meet with JMP Securities
Subscribe for More Information
09:38 EDTXActive equity options trading on open
Subscribe for More Information
September 9, 2014
07:43 EDTADXSAdvaxis provides clinical development updatefor ADXS-HPV
Subscribe for More Information
September 8, 2014
16:00 EDTMRKOptions Update; September 8, 2014
Subscribe for More Information
07:15 EDTRHHBYIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use